Oral potentially malignant disorders (OPMDs) are a risk factor for oral cancer. Histopathological grading is used to detect epithelial dysplasia, and biomarkers can help give more information about abnormalities and disease progression. The expression of Ki-67 and p53 in OPMDs were assessed in the present study and related to histopathological dysplasia. Methodology: A cross sectional analytical study was done in the hospital setting with 100 patients presenting with OPMDs. The epithelial dysplasia was graded as absent, mild, moderate or severe by histopathological examination. Ki-67 and p53 expression was evaluated by immunohistochemistry. The statistical analysis done was chi-square test, ANOVA, Spearman correlation and ordinal logistic regression. Results with a p value of < 0.05 were considered significant. Results: Female was the most common gender, with leukoplakia as the most common type (48%), and 64% of the patients were male. Mild Observed in 10% of cases each, severe dysplasia was observed in 10% of cases each identified in 20%. The level of mean Ki-67 and p53 expression gradually rose with increasing severity of dysplasia (p<0.001). There was a strong positive correlation for dysplasia grade with Ki-67 (r=0.72) and p53 (r=0.68), respectively, (p<0.001). There were significant relationships between both of the biomarkers and the severity of the dysplasia. Conclusion: There were significant associations between increased epithelial dysplasia and Ki-67 and p53 expression. Their combined assessment with conventional histopathology may improve the evaluation of OPMDs and identification of potentially high-risk lesions.
Oral potentially malignant disorders (OPMDs) are a collection of oral mucous disorders that are linked to an increased risk of oral cancer. Higher risk of the development of oral squamous cell carcinoma (OSCC) [1].
It may be in the oral cavity, as in the case of a toothache. The conditions include leukoplakia, erythroplakia, oral submucous fibrosis and oral lichen planus [2]. Though these lesions do not give rise to raised solid forms of the disease. Need not progress to malignancy, but can show cell and structural changes that make a statement about the risk of cancer [3]. Every child, regardless of their condition, should be identified and assessed as early as possible with the utmost accuracy. Thus OPMDs are a crucial component in the diagnosis, management and prevention of malignant transformation [4].
However, there are several potential risk factors for developing OPMDs, including tobacco use, use of betel quid, and certain dietary factors. These are the factors associated with areca nut, gutka, naswar and alcohol consumption [5]. These can lead to chronic epithelial inflammation, oxidative stress, and irritation cause abnormal changes in the cells, which eventually causes genetic changes [6]. Smokeless tobacco use, along with the use of tobacco in general, is prevalent in the South Asian countries including Pakistan and has impacted millions of people in these regions. Oral PML play a major role in the burden of related products [6].
The most common technique for diagnosis and evaluation of the severity of OPMDs is by histopathological examination. Of oral epithelial dysplasia [8]. Typically, dysplasia is considered mild, moderate, or severe according to abnormalities of the cells and/or the architecture. Loss of normal epithelial is an important microscopic feature. The hallmark features of this type of cancer include organization, pleomorphism, nuclear hyperchromatism and elevated nuclear-to-cytoplasm ratio.
These include abnormal mitotic activity [9]. The severity of dysplasia will give a good indication of malignant transformation risk. Yet, grading on a histopathological basis may be subjective and does not reflect the degree of aggressiveness of the tumor. It can always correctly estimate the biological reaction of a single lesion [10].
The importance of biomarkers as complementary tools to assess cellular abnormalities has grown malignant transformation potential. Ki-67 is a cellular proliferation marker which suggests higher cell proliferation. The encoded protein plays a role in division, whereas p53 is a tumour suppressor protein that functions in DNA repair, cell-cycle regulation and. apoptosis [11]. Disruption of these markers' expression can suggest that there is abnormal proliferation of the epithelium. It disrupts normal cell regulation [12]. Other biomarkers, such as p16, cyclin D1 and Bcl-2 have also been studied for their role in the detection of molecular alterations related to oral carcinogenesis [13].
Histopathological analysis along with biomarker evaluation could offer a more A comprehensive understanding of OPMDs is provided. histochemistry detects biochemical alterations. Morphological changes are detected by histopathology and biochemical changes by histochemistry. The severity of dysplasia is determined by the type of cell, while biomarkers provide more information about the severity of dysplasia. Proliferation and abnormalities at the molecular level. Their joint evaluation can enhance the identification of lesions that have characteristics linked to a higher probability of malignant transformation [14].
Research Gap
Although there have been progress in histopathological and molecular evaluation, the prediction of the malignant transformation of OPMDs is still difficult. Histopathological grading may not fully reflect the biological behaviour of lesions and the association of the expression of the biomarkers with the stage of dysplasia is yet to be investigated. There was low incorporation of histopathological results and biomarker expression, especially in high-exposure oral cancers patient population, indicating the need for future studies.
Objective
The aim of this study is to assess the histopathological features and the expression of biomarkers in OPMDs and its relation with the presence and grade of EPMD. It also seeks to evaluate the potential of biomarker assessment as a complementary tool to the traditional histopathological assessment to detect lesions that are at higher risk of malignant transformation.
Study Design, Setting, and Duration
The present study, a cross sectional analytical study was carried out in the department of Oral Pathology and Histopathology for a period of 12 months. This study assessed the association between the grade of oral epithelial dysplasia and Ki-67 and p53 immunohistochemical expression in patients with oral potentially malignant disorders (OPMDs).
Sample Size and Sampling Technique
There were 100 patients who were included using non-probability consecutive sampling. The sample size was determined by the correlation based formula, using an expected correlation coefficient of 0.30, 95% confidence level and 80% statistical power. The calculated minimum sample size was 85, which was raised to 98 by adding 15% due to insufficient specimens and staining. The last sample consisted of 100 patients.
Eligibility Criteria
All patients were included who had clinically suspected, histopathologically confirmed OPMDs and sufficient formalin fixed, paraffin embedded tissue samples. Patients with prior diagnosis of oral squamous cell carcinoma, history of chemotherapy or radiotherapy for oral malignancy, inadequate tissue specimens, extensive necrosis, and inadequate epithelium were excluded and failed immunohistochemical staining.
Clinical Assessment and Histopathological Examination
The demographic and clinical data (age, gender, tobacco use, betel quid or areca nut consumption, alcohol use, lesion site, and clinical appearance) were recorded on a structured proforma. A sample of incisional or excisional biopsies were taken and fixed in 10% neutral buffered formalin. Specimens were routinely processed and embedded in paraffin wax for cutting into 3-5 µm sections. Histological sections were stained with hematoxylin and eosin (H&E) and analysed with the light microscope.
The architectural and cytological changes such as irregular stratification, loss of basal cell polarity, nuclear hyperchromatism, cellular pleomorphism, increased nuclear-to-cytoplasmic ratio, abnormal mitotic figures, premature keratinization, and abnormal rete ridge formation were evaluated for diagnosis of oral epithelial dysplasia. Lesions were graded as non-dysplastic, mild, moderate, and severe dysplasia.
Immunohistochemical Analysis
Paraffin embedded tissue sections were stained with immunohistochemistry for evaluation of the expression of Ki-67 and p53. Sections were deparaffinized, rehydrated and then underwent antigen retrieval. Hydrogen peroxide was used to block endogenous peroxidase, and primary antibodies against Ki-67 and p53 were then used. A proper secondary antibody detection system was used and immunoreactivity was detected with 3,3′-diaminobenzidine (DAB) and then counterstained with hematoxylin. The proper positive and negative controls were employed.
The Ki-67 expression was calculated by counting the percentage of Ki-67-positive epithelial cell nuclei to the total number of epithelial cells in representative fields of view. In the case of p53, the percentage of epithelial cells with nuclear immunoreactivity was documented, as well as the intensity and distribution of immunoreactivity. Comparisons of both biomarkers were made between the grades of epithelial dysplasia.
Quality Control
The slides with the histopathological and immunohistochemical staining were examined independently by two qualified pathologists who were not aware of the other pathologist's interpretations. Consensus review was used to settle any disputes. Suitable staining controls and standardised procedures were employed to provide satisfactory evaluation.
Statistical Analysis
IBM SPSS version 27.0 was used to analyze the data. Categorical data is presented in frequencies and percentages and continuous data is presented as mean ± standard deviation or as median (interquartile range) according to the type of data. The Shapiro–Wilk test was used to determine normality. Chi-square test or Fisher's exact test was used for categorical variables to assess the association. The differences in the expression of Ki-67 and p53 between the dysplasia grades were compared using One-way ANOVA or Kruskal–Wallis test, as appropriate, and appropriate post hoc comparisons were provided.
Spearman's rank correlation methods were used to analyse the relationship between the severity of dysplasia and the levels of expression of the markers. Where appropriate, to determine independent associations after adjustment for clinical and demographic factors, ordinal logistic regression was used. The p value was considered statistically significant if it was < 0.05 on both sides.
There were 100 patients with oral potentially malignant disorders (OPMDs) included in the study. The study population comprised relatively young-to-middle aged with a predominant male population. The exposures most commonly reported were smokeless tobacco; betel quid/areca nut use; and cigarette smoking. The most common clinical pattern was leukoplakia, however other potentially malignant oral lesions were also noted such as oral submucous fibrosis, erythroplakia and oral lichen planus. Demographic and clinical characteristics of the study population are shown in Table 1.
Table 1. Demographic and Clinical Characteristics of the Study Population (n=100)
|
Variables |
Frequency (n) |
Percentage (%) |
|
Age groups (years) |
|
|
|
18–40 |
32 |
32.0 |
|
41–60 |
48 |
48.0 |
|
Above 60 |
20 |
20.0 |
|
Gender |
|
|
|
Male |
64 |
64.0 |
|
Female |
36 |
36.0 |
|
Risk factors |
|
|
|
Smokeless tobacco use |
57 |
57.0 |
|
Betel quid/areca nut use |
31 |
31.0 |
|
Smoking |
22 |
22.0 |
|
Alcohol consumption |
15 |
15.0 |
|
Clinical lesion type |
|
|
|
Leukoplakia |
48 |
48.0 |
|
Oral submucous fibrosis |
25 |
25.0 |
|
Erythroplakia |
12 |
12.0 |
|
Oral lichen planus |
15 |
15.0 |
Histopathological evaluation showed that there was heavy epithelial dysplasia among which moderate and mild dysplasia were the most common grade. Other abnormalities such as architectural and cytological ones were also often present. The architectural alterations that were most prominent were irregular stratification of the epithelium while the most frequently observed cytological abnormality was nuclear hyperchromatism, with cellular pleomorphism next. These results suggest significant morphological changes among the analyzed specimens of OPMD. Table 2 shows a summary of the distribution of dysplasia grades and individual microscopic abnormalities.
Table 2. Histopathological Distribution and Microscopic Features (n=100)
|
Histopathological findings |
Frequency (n) |
Percentage (%) |
|
Dysplasia grade |
|
|
|
Non-dysplastic |
20 |
20.0 |
|
Mild |
30 |
30.0 |
|
Moderate |
30 |
30.0 |
|
Severe |
20 |
20.0 |
|
Architectural abnormalities |
|
|
|
Irregular epithelial stratification |
58 |
58.0 |
|
Loss of basal cell polarity |
43 |
43.0 |
|
Abnormal rete ridge formation |
39 |
39.0 |
|
Premature keratinization |
34 |
34.0 |
|
Cytological abnormalities |
|
|
|
Nuclear hyperchromatism |
62 |
62.0 |
|
Cellular pleomorphism |
54 |
54.0 |
|
Increased nuclear-to-cytoplasmic ratio |
49 |
49.0 |
|
Abnormal mitotic figures |
28 |
28.0 |
Immunohistochemical analysis showed varying expression in the study population of Ki-67 and p53. Ki-67 compared to p53 had a relatively higher mean labeling index and wide range of expression. The observed differences in both markers indicate that cellular proliferative activity and immunoreactivity of p53 varies between different OPMD lesions. The overall expression characteristics of their immunohistochemistry are shown in Table 3.
Table 3. Overall Immunohistochemical Expression of Ki-67 and p53 (n=100)
|
Biomarker |
Mean (%) |
SD |
Minimum–Maximum |
|
Ki-67 labeling index |
19.6 |
13.2 |
1–55 |
|
p53-positive cells |
15.3 |
11.5 |
0–48 |
There was a progressive rise in expression of both Ki-67 and p53 with increasing histopathological severity. Both biomarkers showed the lowest expression in non-dysplastic lesions, and showed increasing expression in mild, moderate and severe dysplasia. This gradient was more pronounced for Ki-67, but was also observed for p53. The mean expression of both biomarkers were demonstrated to be statistically significant different in both across the four histopathological categories (Table 4).
Table 4. Comparison of Ki-67 and p53 Expression According to Dysplasia Grade
|
Dysplasia grade |
n |
Ki-67 mean ± SD (%) |
p53 mean ± SD (%) |
|
Non-dysplastic |
20 |
4.8 ± 2.5 |
3.9 ± 2.1 |
|
Mild |
30 |
11.5 ± 4.2 |
9.2 ± 3.8 |
|
Moderate |
30 |
23.1 ± 6.8 |
18.4 ± 6.1 |
|
Severe |
20 |
37.2 ± 8.5 |
29.7 ± 8.0 |
|
Overall |
100 |
19.6 ± 13.2 |
15.3 ± 11.5 |
|
ANOVA p-value |
|
<0.001 |
<0.001 |
The percentage of lesions with high levels of expression of both Ki-67 and p53 was also correlated with increasing histopathological severity. All cases of severe dysplasia showed high levels of Ki-67, whereas moderate dysplasia cases had 93.3% and mild dysplasia cases had 50% of their specimens expressing high levels of Ki-67. Likewise, 95.0% of severe dysplasia grade, 83.3% of moderate dysplasia grade, and 43.3% of mild dysplasia grade had high level of p53 expression. Grade of dysplasia was significantly associated with both biomarkers (Table 5).
Table 5. Association Between Categorical Biomarker Expression and Dysplasia Grade
|
Dysplasia grade |
Ki-67 low n (%) |
Ki-67 high n (%) |
p53 low n (%) |
p53 high n (%) |
|
Non-dysplastic |
18 (90.0) |
2 (10.0) |
19 (95.0) |
1 (5.0) |
|
Mild |
15 (50.0) |
15 (50.0) |
17 (56.7) |
13 (43.3) |
|
Moderate |
2 (6.7) |
28 (93.3) |
5 (16.7) |
25 (83.3) |
|
Severe |
0 (0.0) |
20 (100.0) |
1 (5.0) |
19 (95.0) |
|
Total |
35 (35.0) |
65 (65.0) |
42 (42.0) |
58 (58.0) |
|
Chi-square p-value |
|
<0.001 |
|
<0.001 |
Strong positive correlation was found between dysplasia severity and Ki-67 and p53 expression with slightly better correlation with Ki-67 (Spearman correlation analysis). Both biomarkers were also significantly correlated with each other. In adjusted ordinal logistic regression, Ki-67 and p53 expression remained significantly correlated with the severity of dysplasia; for every 1% increase in expression, there was a 12% and 7% increase in odds of increasing dysplasia severity, respectively. Age and gender were statistically not associated with dysplasia severity though smokeless tobacco exposure was. The results of these analyses indicate that the expression of each of these immunohistochemical markers is independently associated with histopathological severity; these associations are shown in Table 6.
Table 6. Correlation and Multivariable Analysis of Biomarkers and Dysplasia Severity
|
Variables |
Statistical measure |
Estimate |
95% CI |
p-value |
|
Ki-67 vs. dysplasia grade |
Spearman's rho |
0.72 |
— |
<0.001 |
|
p53 vs. dysplasia grade |
Spearman's rho |
0.68 |
— |
<0.001 |
|
Ki-67 vs. p53 |
Spearman's rho |
0.64 |
— |
<0.001 |
|
Ki-67 expression |
Adjusted OR |
1.12 |
1.07–1.17 |
<0.001 |
|
p53 expression |
Adjusted OR |
1.07 |
1.02–1.12 |
0.004 |
|
Age |
Adjusted OR |
1.02 |
0.99–1.05 |
0.180 |
|
Male gender |
Adjusted OR |
1.31 |
0.61–2.82 |
0.487 |
|
Smokeless tobacco exposure |
Adjusted OR |
2.48 |
1.10–5.59 |
0.028 |
OR = odds ratio; CI = confidence interval. Regression odds ratios for Ki-67 and p53 represent each 1% increase in biomarker expression.
In the present study, the relationship between the histopathological findings of dysplasia and the expression of Ki-67 and p53 has been evaluated in 100 patients diagnosed with OPMD. The findings showed a progressive increase in the severity of the biomarkers with increasing severity of epithelial dysplasia. They found that the level of expression of Ki-67 was positively associated with that of p53 and dysplasia grade, indicating their potential as additional markers of abnormal changes in the epithelium [15].
High prevalence of use of smokeless tobacco and preponderance of male patients was consistent with above what has been found in other South Asian populations [16]. The most prevalent condition was leukoplakia, accounting for 24.4% of all the cases. In the present study, along with earlier study it was observed to be one of the most observed OPMDs [17]. Past studies have shown that malignant tumors of the thyroid gland are treatable. The chances of transformation are dependent on the type of lesion, clinical features and histopathological severity [18].
The progressive increase in Ki-67 expression from non-dysplastic lesions to severe dysplasia was consistent with previous immunohistochemical investigations demonstrating increased epithelial proliferative activity in higher grades of oral epithelial dysplasia [19]. Recent systematic review evidence has also supported the usefulness of Ki-67 in evaluating and grading oral potentially malignant disorders.
Similarly, the increased p53 expression observed with increasing dysplasia severity was supported by previous studies investigating tumor suppressor abnormalities in OPMDs. A systematic review and meta-analysis reported that p53 overexpression was associated with an increased risk of malignant transformation, supporting its potential role in oral cancer risk assessment [20].
.The important correlations and multivariable analysis results confirmed The value of using a combination of biomarker analysis and conventional histopathological analysis. It is noted, however, that literature citations to date have focused on the fact that none of the current biomarkers are able to accurately predict malignant. Transformation in all patients. An integrated approach, combining histopathological results, molecular, and imaging data will be used. A more complete assessment of risk can be undertaken using markers and clinical risk factors [21].
Limitations
There were a few drawbacks to the study. It was not possible to directly assess long-term effects from its cross-sectional design. The single centre and relatively small sample size may have restricted the the applicability of the results. Moreover, only two biomarkers were tested, Ki-67 and p53. There may have been interobserver differences in the staining and interpretation of the immunohistochemical markers.
Future Recommendations
Future multicenter studies with larger sample sizes and longitudinal follow-up are recommended to determine the actual malignant transformation risk of OPMDs. Additional biomarkers, including p16, cyclin D1, and Bcl-2, could also be investigated. Standardized immunohistochemical scoring and combined clinical, histopathological, and molecular assessment may improve risk stratification and support early identification of high-risk lesions.
Repeat multicenter studies with larger numbers of participants and longer follow-up are recommended determine the actual malignant transformation risk of OPMDs. A number of other markers, such as p16, and other proteins such as cyclin D1, and Bcl-2, may be studied. The use of a standardized immunohistochemical score and a clinical, histopathological and molecular evaluation combined may aid in risk stratification facilitate early detection of high risk lesions.